RE:RE:Big pharma is set to keep signing bigger deals in 2024"The M&A environment has kind of woken up a little bit,” according to Jay Stamatis, vice president and head of business development and acquisitions at Abbvie, speaking on March 04, 2024 at Biocom California 2024 Global Life Science Partnering and Investor Conference